These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2498016)

  • 1. Standardization of methods for measuring plasminogen activator inhibitor activity in human plasma.
    Chandler WL; Loo SC; Nguyen SV; Schmer G; Stratton JR
    Clin Chem; 1989 May; 35(5):787-93. PubMed ID: 2498016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay.
    Eriksson E; Rånby M; Gyzander E; Risberg B
    Thromb Res; 1988 Apr; 50(1):91-101. PubMed ID: 3135638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of plasminogen activator inhibitor (PAI) capacity of human plasma in presence of oxidants: a novel principle.
    Stief TW; Lenz P; Becker U; Heimburger N
    Thromb Res; 1988 May; 50(4):559-73. PubMed ID: 3137681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of the concentration of free plasminogen activator inhibitor (PAI-1) and its complex with tissue plasminogen activator in human plasma.
    Takada Y; Takada A
    Thromb Res Suppl; 1988; 8():15-22. PubMed ID: 3144765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.
    Lucore CL; Fujii S; Sobel BE
    Circulation; 1989 Jun; 79(6):1204-13. PubMed ID: 2498004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C; Jie AF; Rijken DC; Verheijen JH
    Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of tissue plasminogen activator and its "fast" inhibitor in plasma.
    Chmielewska J; Wiman B
    Clin Chem; 1986 Mar; 32(3):482-5. PubMed ID: 3081282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA; Fernández Diaz FJ; Rocha E
    Thromb Haemost; 1988 Jun; 59(3):451-4. PubMed ID: 3142082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2.
    Thorsen S; Philips M; Selmer J; Lecander I; Astedt B
    Eur J Biochem; 1988 Jul; 175(1):33-9. PubMed ID: 3136015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED
    Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plasminogen activator inhibitor (PAI-2) circulates in two molecular forms during pregnancy.
    Booth NA; Reith A; Bennett B
    Thromb Haemost; 1988 Feb; 59(1):77-9. PubMed ID: 3129811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1).
    de Maat MP; Kluft C; de Boer K; Knot EA; Jie AF
    Thromb Res; 1988 Dec; 52(5):425-30. PubMed ID: 3146821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.
    Lucore CL; Sobel BE
    Circulation; 1988 Mar; 77(3):660-9. PubMed ID: 2449299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C.
    Fay WP; Owen WG
    Biochemistry; 1989 Jul; 28(14):5773-8. PubMed ID: 2505842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C; Angles-Cano E
    Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
    Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
    Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.
    Medcalf RL; Van den Berg E; Schleuning WD
    J Cell Biol; 1988 Mar; 106(3):971-8. PubMed ID: 3126194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.
    Wiman B; Lindahl T; Almqvist A
    Thromb Haemost; 1988 Jun; 59(3):392-5. PubMed ID: 3142076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.